Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
cebpaxenopus   

Too many results?Too few results?

Experiment details for cebpa

Nkx2.5 is involved in myeloid cell differentiation at anterior ventral blood islands in the Xenopus embryo.

Nkx2.5 is involved in myeloid cell differentiation at anterior ventral blood islands in the Xenopus embryo.

Gene Clone Species Stages Anatomy
cebpa.L laevis NF stage 18 anterior ventral blood island , myeloid cell

Display additional annotations [+]
  Fig. 3. Nkx2.5 is necessary for differentiation of heart and myeloid cells in dorsal marginal zone (DMZ) explants. Embryos were injected with Control morpholino oligos (MO) (18.4 pmol/embryo) (b, e, h) and with Nkx2.5 MO (18.4 pmol/embryo) (c, f, i) into the DMZ region at the 4-cell stage. Intact embryos served as controls (a, d, g). DMZ explants excised from these embryos were cultured until st. 18 and processed for whole-mount in situ hybridization to examine the expression of c/ebpa (a, b, c), spib (d, e, f), and mpo (g, h, i). The number in each panel indicates total number of samples from three independent experiments. As was observed in the experiment using whole embryos, expression of myeloid cell markers was suppressed by injection of Nkx2.5 MO (c, f, i). In contrast, expression of myeloid cell markers was not affected by injection of Control MO (d, e, f).